ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q1SCImago #3,490Hybrid

Future Oncology

Abbreviation (ISO):FUTURE ONCOL
•
Identifier (ISSN):1479-6694(Print)/1744-8301(Online)
•
Publisher:Future Medicine Ltd.
Clarivate IF (2026)
3.1↑ +0.5
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Future Oncology

WoS Q2
12452.3720182.2820192.6620203.420213.6720223.32023320242.620253.12026
Annual Impact Factor Metric
Current (2026):3.1
Scopus SJR & RankScopus Q1
1.229
#3,490

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
102

102 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate3.3%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
390articles/year
23.77% Gold OA•82.55% Original Research

Aims & Scope

Future Oncology (ISSN 1479-6694) provides a forum for a new era of cancer care. The journal focuses on the most important advances and highlights their relevance in the clinical setting. Furthermore, Future Oncology delivers essential information in concise, at-a-glance article formats - vital in delivering information to an increasingly time-constrained community. The journal takes a forward-looking stance toward the scientific and clinical issues, together with the economic and policy issues that confront us in this new era of cancer care. The journal includes literature awareness such as the latest developments in radiotherapy and immunotherapy, concise commentary and analysis, and full review articles all of which provide key findings, translational to the clinical setting.

Topics Covered (Recognized by AI)
Medicine99.6%Biology92%Internal medicine92%Genetics86.8%Cancer71%Oncology67.3%Pathology59.7%Surgery45.9%Chemistry42.5%Biochemistry37.4%Cancer research32.7%Immunology29.5%Chemotherapy22.8%Gene21.5%Radiology21%Bioinformatics20.3%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ONCOLOGY

Q2
Rank165/333
IndexSCIE
JCISCIE2026

ONCOLOGY

Q3
Rank185/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.1
Articles / Year190
Total Citations62
2025
IF2.6
Articles / Year351
Total Citations729
2024
IF3
Articles / Year307
Total Citations1,619
2023
IF3.3
Articles / Year298
Total Citations2,222
2022
IF3.674
Articles / Year353
Total Citations4,009

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #3,490Scopus Q1SCImago Profile
Scopus Coverage:2005-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q1
1.229

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
2.61

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,332 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,718
3-Year Documents948
Citable Documents896

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)3

Citations in government and international policy documents

Female Author Rate41.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q1
OncologyQ1
Cancer ResearchQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 3.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Future Oncology (abbr: FUTURE ONCOL, ISSN: 1479-6694) is a peer-reviewed international scholarly journal in the field of ONCOLOGY, published by Future Medicine Ltd. in England since 2005. The periodical holds a Journal Impact Factor (JIF) of 3.10, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.229 (Q1), an H-index of 102.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 390 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,332 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Future Medicine Ltd.
Publication Language
English
Frequency
Monthly
Founding Year
2005
Indexing & Databases
SCIEScopusPubMed
Editorial Address
FUTURE MEDICINE LTD, UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, ENGLAND, N3 1QB

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: d16d6fcd-9895-455d-84a1-80af40e5533e
Database Updated: 2026-10-01